ABSCF
Price
$1.26
Change
-$0.34 (-21.25%)
Updated
Jun 6 closing price
Capitalization
207.79M
ARSUF
Price
$20.03
Change
-$0.82 (-3.93%)
Updated
Oct 29 closing price
Capitalization
1.27B
Interact to see
Advertisement

ABSCF vs ARSUF

Header iconABSCF vs ARSUF Comparison
Open Charts ABSCF vs ARSUFBanner chart's image
AB Science, Paris
Price$1.26
Change-$0.34 (-21.25%)
Volume$400
Capitalization207.79M
Fagron SA
Price$20.03
Change-$0.82 (-3.93%)
Volume$425
Capitalization1.27B
ABSCF vs ARSUF Comparison Chart in %
Loading...
ABSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSCF vs. ARSUF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSCF is a Hold and ARSUF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ABSCF: $1.26 vs. ARSUF: $20.03)
Brand notoriety: ABSCF and ARSUF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ABSCF: 110% vs. ARSUF: 100%
Market capitalization -- ABSCF: $207.79M vs. ARSUF: $1.27B
ABSCF [@Pharmaceuticals: Other] is valued at $207.79M. ARSUF’s [@Pharmaceuticals: Other] market capitalization is $1.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSCF’s FA Score shows that 0 FA rating(s) are green whileARSUF’s FA Score has 1 green FA rating(s).

  • ABSCF’s FA Score: 0 green, 5 red.
  • ARSUF’s FA Score: 1 green, 4 red.
According to our system of comparison, ARSUF is a better buy in the long-term than ABSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSCF’s TA Score shows that 4 TA indicator(s) are bullish.

  • ABSCF’s TA Score: 4 bullish, 2 bearish.

Price Growth

ABSCF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while ARSUF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARSUF($1.27B) has a higher market cap than ABSCF($208M). ABSCF YTD gains are higher at: 40.000 vs. ARSUF (0.000). ARSUF has higher annual earnings (EBITDA): 136M vs. ABSCF (-11.41M). ARSUF has more cash in the bank: 119M vs. ABSCF (8.72M). ABSCF has less debt than ARSUF: ABSCF (8.35M) vs ARSUF (385M). ARSUF has higher revenues than ABSCF: ARSUF (727M) vs ABSCF (1.61M).
ABSCFARSUFABSCF / ARSUF
Capitalization208M1.27B16%
EBITDA-11.41M136M-8%
Gain YTD40.0000.000-
P/E RatioN/A17.83-
Revenue1.61M727M0%
Total Cash8.72M119M7%
Total Debt8.35M385M2%
FUNDAMENTALS RATINGS
ABSCF vs ARSUF: Fundamental Ratings
ABSCF
ARSUF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9960
PRICE GROWTH RATING
1..100
6458
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
n/a25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARSUF's Valuation (28) in the null industry is somewhat better than the same rating for ABSCF (62). This means that ARSUF’s stock grew somewhat faster than ABSCF’s over the last 12 months.

ARSUF's Profit vs Risk Rating (100) in the null industry is in the same range as ABSCF (100). This means that ARSUF’s stock grew similarly to ABSCF’s over the last 12 months.

ARSUF's SMR Rating (60) in the null industry is somewhat better than the same rating for ABSCF (99). This means that ARSUF’s stock grew somewhat faster than ABSCF’s over the last 12 months.

ARSUF's Price Growth Rating (58) in the null industry is in the same range as ABSCF (64). This means that ARSUF’s stock grew similarly to ABSCF’s over the last 12 months.

ARSUF's P/E Growth Rating (55) in the null industry is somewhat better than the same rating for ABSCF (100). This means that ARSUF’s stock grew somewhat faster than ABSCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABSCFARSUF
RSI
ODDS (%)
Bullish Trend 5 days ago
10%
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
Bullish Trend 5 days ago
28%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
26%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
18%
Bullish Trend 5 days ago
20%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
42%
Bullish Trend 5 days ago
22%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
10%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUITX24.470.27
+1.12%
Buffalo Mid Cap Discovery Inst
TSMNX15.600.15
+0.97%
Nuveen Quant Small/Mid Cap Eq I
DAACX10.260.08
+0.79%
SEI Diversified Equity
TWEAX8.770.02
+0.23%
American Century Equity Income A
VLSIX17.770.01
+0.06%
Virtus KAR Long/Short Equity I

ABSCF and

Correlation & Price change

A.I.dvisor tells us that ABSCF and ALID have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABSCF and ALID's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSCF
1D Price
Change %
ABSCF100%
N/A
ALID - ABSCF
16%
Poorly correlated
N/A
YCBD - ABSCF
3%
Poorly correlated
-6.40%
APNHF - ABSCF
1%
Poorly correlated
N/A
ARSUF - ABSCF
0%
Poorly correlated
N/A
APNHY - ABSCF
0%
Poorly correlated
+3.27%
More

ARSUF and

Correlation & Price change

A.I.dvisor tells us that ARSUF and GENPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and GENPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
GENPF - ARSUF
23%
Poorly correlated
N/A
AVCNF - ARSUF
11%
Poorly correlated
+0.66%
ALID - ARSUF
8%
Poorly correlated
N/A
BOIRF - ARSUF
1%
Poorly correlated
N/A
BIOVF - ARSUF
1%
Poorly correlated
N/A
More